Slow CD4(+) T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana

Background. Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) coinfection has emerged as an important cause of morbidity and mortality. We determined the response to Truvada-based first-line combination antiretroviral therapy (cART) in HIV/HBV-coinfected verus HIV-monoinfected patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Motswedi, Gaseitsiwe, Simani, Moyo, Sikhulile, Thami, Kerapetse P., Mohammed, Terence, Setlhare, Ditiro, Sebunya, Theresa K., Powell, Eleanor A., Makhema, Joseph, Blackard, Jason T., Marlink, Richard, Essex, Max, Musonda, Rosemary M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084712/
https://www.ncbi.nlm.nih.gov/pubmed/27800524
http://dx.doi.org/10.1093/ofid/ofw140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084712/
https://www.ncbi.nlm.nih.gov/pubmed/27800524
http://dx.doi.org/10.1093/ofid/ofw140

Ejemplares similares